All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Myriad Genetics, Inc. revenue reports

Myriad Genetics, Inc. financial reports, Myriad Genetics, Inc. annual revenue in 2024. When does Myriad Genetics, Inc. report revenue?
Add to widgets
Added to widgets

Myriad Genetics, Inc. total revenue, net income and dynamics of changes in US dollar today

Net income Myriad Genetics, Inc. - -39 500 000 $. Information about net income is used from open sources. The dynamics of Myriad Genetics, Inc. net income grew by 4 700 000 $ for the last reporting period. Net income, revenue and dynamics - the main financial indicators of Myriad Genetics, Inc.. Chart of online financial report of Myriad Genetics, Inc.. The financial report schedule from 30/06/2017 to 31/03/2021 is available online. Information on Myriad Genetics, Inc. net income on the chart on this page is drawn in blue bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 173 100 000 $ -20.0831 % ↓ -39 500 000 $ -672.464 % ↓
31/12/2020 154 600 000 $ -20.759 % ↓ -44 200 000 $ -
30/09/2020 145 200 000 $ -22.0612 % ↓ -15 200 000 $ -
30/06/2020 93 200 000 $ -56.732 % ↓ -55 400 000 $ -
31/12/2019 195 100 000 $ - -8 300 000 $ -
30/09/2019 186 300 000 $ - -20 600 000 $ -
30/06/2019 215 400 000 $ - -4 200 000 $ -
31/03/2019 216 600 000 $ - 6 900 000 $ -
31/12/2018 216 800 000 $ - 2 600 000 $ -
30/09/2018 202 300 000 $ - -700 000 $ -
30/06/2018 194 900 000 $ - 6 500 000 $ -
31/03/2018 193 500 000 $ - 11 400 000 $ -
31/12/2017 194 000 000 $ - 32 100 000 $ -
30/09/2017 190 200 000 $ - 81 100 000 $ -
30/06/2017 200 500 000 $ - 12 800 000 $ -
Show:
to

Myriad Genetics, Inc. financial report charts

The dates of the latest financial statements of Myriad Genetics, Inc.: 30/06/2017, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of Myriad Genetics, Inc. for today is 31/03/2021. Gross profit Myriad Genetics, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Myriad Genetics, Inc. is 122 800 000 $

Myriad Genetics, Inc. quarterly report dates

Cost of revenue Myriad Genetics, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Myriad Genetics, Inc. is 50 300 000 $ Total revenue Myriad Genetics, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Myriad Genetics, Inc. is 173 100 000 $ Operating income Myriad Genetics, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Myriad Genetics, Inc. is -45 800 000 $

Net income Myriad Genetics, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Myriad Genetics, Inc. is -39 500 000 $ Current assets Myriad Genetics, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Myriad Genetics, Inc. is 329 200 000 $ Total assets Myriad Genetics, Inc. refers to the total amount of assets owned by a person or entity. Total assets Myriad Genetics, Inc. is 1 336 900 000 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018 31/03/2018 31/12/2017 30/09/2017 30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
122 800 000 $ 107 500 000 $ 101 000 000 $ 56 500 000 $ 145 500 000 $ 136 600 000 $ 164 800 000 $ 168 000 000 $ 164 700 000 $ 152 600 000 $ 149 100 000 $ 149 400 000 $ 149 600 000 $ 147 200 000 $ 157 900 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
50 300 000 $ 47 100 000 $ 44 200 000 $ 36 700 000 $ 49 600 000 $ 49 700 000 $ 50 600 000 $ 48 600 000 $ 52 100 000 $ 49 700 000 $ 45 800 000 $ 44 100 000 $ 44 400 000 $ 43 000 000 $ 42 600 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
173 100 000 $ 154 600 000 $ 145 200 000 $ 93 200 000 $ 195 100 000 $ 186 300 000 $ 215 400 000 $ 216 600 000 $ 216 800 000 $ 202 300 000 $ 194 900 000 $ 193 500 000 $ 194 000 000 $ 190 200 000 $ 200 500 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - 195 100 000 $ 186 300 000 $ 215 400 000 $ 216 600 000 $ 216 800 000 $ 202 300 000 $ 194 900 000 $ 193 500 000 $ 194 000 000 $ 190 200 000 $ 200 500 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-45 800 000 $ -43 600 000 $ -40 700 000 $ -68 300 000 $ -7 600 000 $ -20 200 000 $ -3 800 000 $ 10 100 000 $ 11 000 000 $ 11 200 000 $ 9 800 000 $ 17 000 000 $ 4 400 000 $ 87 400 000 $ 19 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-39 500 000 $ -44 200 000 $ -15 200 000 $ -55 400 000 $ -8 300 000 $ -20 600 000 $ -4 200 000 $ 6 900 000 $ 2 600 000 $ -700 000 $ 6 500 000 $ 11 400 000 $ 32 100 000 $ 81 100 000 $ 12 800 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
23 100 000 $ 18 200 000 $ 17 600 000 $ 17 400 000 $ 18 800 000 $ 21 300 000 $ 21 600 000 $ 21 400 000 $ 21 800 000 $ 21 100 000 $ 17 700 000 $ 18 500 000 $ 16 800 000 $ 17 800 000 $ 18 800 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
218 900 000 $ 198 200 000 $ 185 900 000 $ 161 500 000 $ 202 700 000 $ 206 500 000 $ 219 200 000 $ 206 500 000 $ 205 800 000 $ 191 100 000 $ 185 100 000 $ 132 400 000 $ 145 200 000 $ 59 800 000 $ 138 900 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
329 200 000 $ 389 400 000 $ 394 500 000 $ 331 700 000 $ 365 300 000 $ 329 500 000 $ 348 600 000 $ 342 900 000 $ 336 800 000 $ 341 900 000 $ 326 400 000 $ 331 500 000 $ 327 000 000 $ 325 600 000 $ 317 100 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
1 336 900 000 $ 1 418 800 000 $ 1 444 500 000 $ 1 404 600 000 $ 1 578 300 000 $ 1 591 200 000 $ 1 562 700 000 $ 1 557 300 000 $ 1 556 600 000 $ 1 573 600 000 $ 1 174 100 000 $ 1 218 500 000 $ 1 228 500 000 $ 1 228 300 000 $ 1 224 400 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
148 900 000 $ 117 000 000 $ 118 300 000 $ 163 700 000 $ 81 200 000 $ 89 900 000 $ 93 200 000 $ 84 900 000 $ 90 600 000 $ 93 300 000 $ 110 900 000 $ 97 400 000 $ 88 700 000 $ 87 900 000 $ 102 400 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 112 400 000 $ 115 400 000 $ 117 800 000 $ 108 900 000 $ 113 300 000 $ 108 000 000 $ 102 200 000 $ - - - -
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - - - - - 157 300 000 $ 143 500 000 $ 148 300 000 $ 150 700 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 501 000 000 $ 516 700 000 $ 473 800 000 $ 475 600 000 $ 492 500 000 $ 471 400 000 $ 209 200 000 $ - - - -
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 31.74 % 32.47 % 30.32 % 30.54 % 31.64 % 29.96 % 17.82 % - - - -
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
875 200 000 $ 879 900 000 $ 909 300 000 $ 918 200 000 $ 1 077 200 000 $ 1 074 500 000 $ 1 088 900 000 $ 1 081 800 000 $ 1 064 200 000 $ 1 102 200 000 $ 964 900 000 $ 948 300 000 $ 914 200 000 $ 870 900 000 $ 778 200 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -1 900 000 $ 15 800 000 $ 31 500 000 $ 6 600 000 $ 37 800 000 $ 7 800 000 $ 47 900 000 $ 11 500 000 $ 33 000 000 $ 23 500 000 $ 36 600 000 $

Last revenue report of Myriad Genetics, Inc. was 31/03/2021. According to last financial report total revenue in Myriad Genetics, Inc. was 173 100 000 US dollar and changed by -20.0831% since last year. Net income in Myriad Genetics, Inc. was -39 500 000 $ in last quartal, net income changes to -672.464%.

Current cash Myriad Genetics, Inc. - the sum of all of the cash a company has on the date of report. Current cash Myriad Genetics, Inc. is 148 900 000 $

Myriad Genetics, Inc. stocks data

Myriad Genetics, Inc. financials